The DOI matches its Crossref record; 112 of the 112 references it cites were found in a registry or an index.
DNA methyltransferase inhibitors—state of the art
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Okano, M., Bell, D. W., Haber, D. A., & Li, E. (1999) · Cell · doi:10.1016/s0092-8674(00)81656-6 · Cited by 6,143
Targeted mutation of the DNA methyltransferase gene results in embryonic lethality
Li, E., Bestor, T. H., & Jaenisch, R. (1992) · Cell · doi:10.1016/0092-8674(92)90611-f · Cited by 3,984
CpG-rich islands and the function of DNA methylation
Bird, A. P. (1986) · Nature · doi:10.1038/321209a0 · Cited by 3,777
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
Nan, X., Ng, H.-H., Johnson, C. A., Laherty, C. D., Turner, B. M., Eisenman, R. N., & Bird, A. (1998) · Nature · doi:10.1038/30764 · Cited by 3,440
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,986
Role for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1993) · Nature · doi:10.1038/366362a0 · Cited by 1,964
Cellular differentiation, cytidine analogs and DNA methylation
Jones, P. A., & Taylor, S. M. (1980) · Cell · doi:10.1016/0092-8674(80)90237-8 · Cited by 1,831 · cited 1×
“In comparison to azacitidine and decitabine, DHAC has shown less inhibition of DNA methylation [166].”
BackgroundRole for DNA methylation in genomic imprinting
Li, E., Beard, C., & Jaenisch, R. (1994) · Trends in Genetics · doi:10.1016/0168-9525(94)90228-3 · Cited by 1,691
Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases
Okano, M., Xie, S., & Li, E. (1998) · Nature Genetics · doi:10.1038/890 · Cited by 1,651
DNA hypermethylation in tumorigenesis: epigenetics joins genetics
Baylin, S. B., & Herman, J. G. (2000) · Trends in Genetics · doi:10.1016/s0168-9525(99)01971-x · Cited by 1,628
Cytosine methylation and the ecology of intragenomic parasites
Yoder, J. A., Walsh, C. P., & Bestor, T. H. (1997) · Trends in Genetics · doi:10.1016/s0168-9525(97)01181-5 · Cited by 1,562
Herman, J. G., Merlo, A. U., Mao, L., Lapidus, R. G., Issa, J. J., Davidson, N. E., Sidransky, D., & Baylin, S. B. (1995) · PubMed · Cited by 1,341
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,275
A targeting sequence directs DNA methyltransferase to sites of DNA replication in mammalian nuclei
Leonhardt, H., Page, A. W., Weier, H.-U., & Bestor, T. H. (1992) · Cell · doi:10.1016/0092-8674(92)90561-p · Cited by 1,055
DNMT1 binds HDAC2 and a new co-repressor, DMAP1, to form a complex at replication foci
Rountree, M. R., Bachman, K. E., & Baylin, S. B. (2000) · Nature Genetics · doi:10.1038/77023 · Cited by 1,052
Number of CpG islands and genes in human and mouse.
Antequera, F., & Bird, A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.24.11995 · Cited by 996
Belinsky, S. A., Nikula, K. J., Palmisano, W. A., Michels, R., Saccomanno, G., Gabrielson, E., Baylin, S. B., & Herman, J. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.20.11891 · Cited by 956
Robertson, K. D., Ait-Si-Ali, S., Yokochi, T., Wade, P. A., Jones, P. L., & Wolffe, A. P. (2000) · Nature Genetics · doi:10.1038/77124 · Cited by 942
Human DNA-(Cytosine-5) Methyltransferase-PCNA Complex as a Target for p21 WAF1
Chuang, L. S.-H., Ian, H.-I., Koh, T.-W., Ng, H.-H., Xu, G., & Li, B. F. L. (1997) · Science · doi:10.1126/science.277.5334.1996 · Cited by 902
A Southwest Oncology Group study
Jenkins, T. R., Tangen, C. M., Macdonald, J. S., Weiss, G. R., Chapman, R. M., & Hantel, A. (1993) · Cited by 773
Effects of DNA methylation on DNA-binding proteins and gene expression
Tate, P. H., & Bird, A. P. (1993) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(93)90027-m · Cited by 737 · cited 1×
“It can directly interfere with the binding of transcription factors to inhibit replication [24].”
BackgroundDNA methylation, methyltransferases, and cancer
Robertson, K. D. (2001) · Oncogene · doi:10.1038/sj.onc.1204341 · Cited by 736
Rapp, E., Pater, J. L., Willan, A., Cormier, Y., Murray, N., Evans, W. K., Hodson, D. I., Clark, D. A., Feld, R., & Arnold, A. M. (1988) · Journal of Clinical Oncology · doi:10.1200/jco.1988.6.4.633 · Cited by 698
Jüttermann, R., Li, E., & Jaenisch, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.11797 · Cited by 678
Recombinant Human DNA (Cytosine-5) Methyltransferase
Pradhan, S., Bacolla, A., Wells, R. D., & Roberts, R. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.46.33002 · Cited by 651
Creusot, F., Acs, G., & Christman, J. K. (1982) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)68144-5 · Cited by 564
5-Azacytidine Selectively Increases γ-Globin Synthesis in a Patient with β+Thalassemia
Ley, T. J., DeSimone, J., Anagnou, N. P., Keller, G. H., Humphries, R. K., Turner, P. H., Young, N. S., Heller, P., & Nienhuis, A. W. (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072401 · Cited by 490
CpG methylation is maintained in human cancer cells lacking DNMT1
Rhee, I., Jair, K.-W., Yen, R.-W. C., Lengauer, C., Herman, J. G., Kinzler, K. W., Vogelstein, B., Baylin, S. B., & Schuebel, K. E. (2000) · Nature · doi:10.1038/35010000 · Cited by 453
Barlow, D. P. (1995) · Science · doi:10.1126/science.270.5242.1610 · Cited by 435
Buyse, M., Thirion, P., Carlson, R. W., Burzykowski, T., Molenberghs, G., & Piedbois, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02528-9 · Cited by 427
Dnmt2 is not required for de novo and maintenance methylation of viral DNA in embryonic stem cells
Okano, M. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.11.2536 · Cited by 423
Changes in DNA Methylation in Neoplasia: Pathophysiology and Therapeutic Implications
Santini, V., Kantarjian, H. M., & Issa, J.-P. (2001) · Annals of Internal Medicine · doi:10.7326/0003-4819-134-7-200104030-00011 · Cited by 414
Sloane, J. P., & Ormerod, M. G. (1981) · Cancer · doi:10.1002/1097-0142(19810401)47:7<1739::aid-cncr2820470702>3.0.co;2-2 · Cited by 405
On the mechanism of inhibition of DNA-cytosine methyltransferases by cytosine analogs
Santi, D. V., Garrett, C. E., & Barr, P. J. (1983) · Cell · doi:10.1016/0092-8674(83)90327-6 · Cited by 401
5-Azacytidine stimulates fetal hemoglobin synthesis in anemic baboons.
DeSimone, J., Heller, P., Hall, L., & Zwiers, D. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.14.4428 · Cited by 384 · cited 1×
“In another line of evidence supporting the activity of demethylation, azacitidine caused hypomethylation of the γ-globin gene and induction of fetal hemoglobin production in a human and baboons [99, 100].”
BackgroundBender, C. M., Pao, M. M., & Jones, P. A. (1998) · PubMed · Cited by 380
Deng, G., Chen, A., Hong, J. C., Chae, H. S., & Kim, Y. S. (1999) · PubMed · Cited by 374
Eukaryotic DNA methylation as an evolutionary device
Colot, V., & Rossignol, J.-L. (1999) · BioEssays · doi:10.1002/(sici)1521-1878(199905)21:5<402::aid-bies7>3.0.co;2-b · Cited by 333
Aapola, U., Shibuya, K., Scott, H. S., Ollila, J., Vihinen, M., Heino, M., Shintani, A., Kawasaki, K., Minoshima, S., Krohn, K., et al. (2000) · Genomics · doi:10.1006/geno.2000.6168 · Cited by 317
Nuovo, G. J., Plaia, T. W., Belinsky, S. A., Baylin, S. B., & Herman, J. G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.22.12754 · Cited by 314
Hypermethylation can selectively silence individual p16ink4A alleles in neoplasia.
Myöhänen, S., Baylin, S. B., & Herman, J. G. (1998) · PubMed · Cited by 302
Loss of methylation activates Xist in somatic but not in embryonic cells.
Beard, C., Li, E., & Jaenisch, R. (1995) · Genes & Development · doi:10.1101/gad.9.19.2325 · Cited by 298
Vertino, P. M., Yen, R.-W. C., Gao, J., & Baylin, S. B. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.8.4555 · Cited by 288
A candidate mammalian DNA methyltransferase related to pmt1p of fission yeast
Yoder, J. (1998) · Human Molecular Genetics · doi:10.1093/hmg/7.2.279 · Cited by 281
Chemotherapy for acute myelogenous leukemia in children and adults: VAPA update
Weinstein, H., Mayer, R., Rosenthal, D., Coral, F., Camitta, B., & Gelber, R. (1983) · Blood · doi:10.1182/blood.v62.2.315.315 · Cited by 277
DNA methylation in early development
Razin, A., & Shemer, R. (1995) · Human Molecular Genetics · doi:10.1093/hmg/4.suppl_1.1751 · Cited by 277
Hypomethylation of pericentromeric DNA in breast adenocarcinomas
Narayan, A., Ji, W., Zhang, X.-Y., Marrogi, A., Graff, J. R., Baylin, S. B., & Ehrlich, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980911)77:6<833::aid-ijc6>3.0.co;2-v · Cited by 266
Cytotoxicity and mode of action of 5-azacytidine on L1210 leukemia.
Li, L. H., Olin, E. J., Buskirk, H. H., & REINEKE, L. M. (1970) · PubMed · Cited by 263
Florl, A. R., Löwer, R., Schmitz-Dräger, B. J., & Schulz, W. A. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690524 · Cited by 255
(1996) · PubMed · Cited by 242
Histone deacetylase as a new target for cancer chemotherapy
Yoshida, M., Furumai, R., Nishiyama, M., Komatsu, Y., Nishino, N., & Horinouchi, S. (2001) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800100300 · Cited by 215
Otterson, G. A., Khleif, S. N., Chen, W., Coxon, A. B., & Kaye, F. J. (1995) · PubMed · Cited by 212
Momparler, R. L., Bouffard, D. Y., Momparler, L. F., Dionne, J., B??langer, K., & Ayoub, J. (1997) · Anti-Cancer Drugs · doi:10.1097/00001813-199704000-00008 · Cited by 210
Gelmon, K. A., Eisenhauer, E. A., Harris, A. L., Ratain, M. J., & Workman, P. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.15.1281 · Cited by 204
Self-citationMethylation, mutation and cancer
Jones, P. A., Rideout, W. M., Shen, J., Spruck, C. H., & Tsai, Y. C. (1992) · BioEssays · doi:10.1002/bies.950140107 · Cited by 202
Christman, J. K., Mendelsohn, N., Herzog, D., & Schneiderman, N. (1983) · PubMed · Cited by 185
Sacchi, S., Kantarjian, H. M., O'Brien, S., Cortes, J., Rios, M. B., Giles, F. J., Beran, M., Koller, C. A., Keating, M. J., & Talpaz, M. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19991215)86:12<2632::aid-cncr7>3.0.co;2-a · Cited by 184
Phase I study on 5-aza-2′-deoxycytidine in children with acute leukemia
Rivard, G. E., Momparler, R. L., Demers, J., Benoit, P., Raymond, R., Lin, K.-T., & Momparler, L. F. (1981) · Leukemia Research · doi:10.1016/0145-2126(81)90116-8 · Cited by 181
Frequent Hypomethylation in Wilms Tumors of Pericentromeric DNA in Chromosomes 1 and 16
Qu, G.-Z., Grundy, P. E., Narayan, A., & Ehrlich, M. (1999) · Cancer Genetics and Cytogenetics · doi:10.1016/s0165-4608(98)00143-5 · Cited by 179
Pinto, A., Attadia, V, Fusco, A., Ferrara, F., Spada, O., & Di Fiore, P. (1984) · Blood · doi:10.1182/blood.v64.4.922.922 · Cited by 175
A 1-kb Alu-mediated germ-line deletion removing BRCA1 exon 17.
Puget, N., Torchard, D., Sinilnikova, O. M., Lynch, H. T., Feunteun, J., Lenoir, G., & Mazoyer, S. (1997) · PubMed · Cited by 174
Inhibition of tumorigenesis by a cytosine–DNA, methyltransferase, antisense oligodeoxynucleotide
Ramchandani, S., MacLeod, A. R., Pinard, M., von Hofe, E., & Szyf, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.684 · Cited by 172
Lübbert, M. (2000) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59696-4_9 · Cited by 169
Abnormal regulation of DNA methyltransferase expression during colorectal carcinogenesis.
Marzo, A. M. D., Marchi, V. L., Yang, E. S.-H., Veeraswamy, R., Lin, X. S., & Nelson, W. G. (1999) · PubMed · Cited by 164
Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats
Small, K., Iber, J., & Warren, S. T. (1997) · Nature Genetics · doi:10.1038/ng0597-96 · Cited by 161
MacLeod, A. R., & Szyf, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.14.8037 · Cited by 159
A sex chromosome rearrangement in a human XX male caused by Alu—Alu recombination
Rouyer, F., Simmler, M., Page, D. C., & Weissenbach, J. (1987) · Cell · doi:10.1016/0092-8674(87)90637-4 · Cited by 157
Qu, G.-Z., Dubeau, L., Narayan, A., Yu, M. C., & Ehrlich, M. (1999) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(98)00229-2 · Cited by 148
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
Kantharidis, P., El‐Osta, A., DeSilva, M., Wall, D. M., Hu, X. F., Slater, A. A., Nadalin, G., Parkin, J. D., & Zalcberg, J. R. (1997) · PubMed · Cited by 144
Clinical trial on 5-AZA-2′-deoxycytidine in patients with acute leukemia
Momparler, R. L., Rivard, G., & Gyger, M. (1985) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(85)90052-x · Cited by 143
Wachsman, J. T. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00003-1 · Cited by 143
Thibault, A., Figg, W. D., Bergan, R. C., Lush, R. M., Myers, C. E., Tompkins, A. C., Reed, E., & Samid, D. (1998) · Tumori Journal · doi:10.1177/030089169808400120 · Cited by 140
Effect of 5-aza-2'-deoxycytidine against leukemic and hemopoietic tissues in AKR mice.
Šorm, F., & Veselý, J. (1968) · PubMed · Cited by 134
Results of decitabine therapy in the accelerated and blastic phases of chronic myelogenous leukemia
Kantarjian, H., O'Brien, S., Keating, M. J., Beran, M., Estey, E. H., Giralt, S. A., Kornblau, S. M., Rios, M., Vos, D. D., & Talpaz, M. (1997) · Leukemia · doi:10.1038/sj.leu.2400796 · Cited by 130
Methylation of DNA in Prokaryotes
Noyer-Weidner, M., & Trautner, T. A. (1993) · Birkhäuser Basel eBooks · doi:10.1007/978-3-0348-9118-9_4 · Cited by 124
Abele, R., Clavel, M., Dodion, P. F., Bruntsch, U., Gundersen, S., Smyth, J., Renard, J., Glabbeke, M. M. V., & Pinedo, H. M. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90060-5 · Cited by 120
Phase I and pharmacokinetic study of 5-aza-2'-deoxycytidine (NSC 127716) in cancer patients.
van Groeningen, C. J., LEYVA, A., O'Brien, A. M. P., Gall, H. E., & Pinedo, H. M. (1986) · PubMed · Cited by 119
Wilson, V. L., Jones, P. A., & Momparler, R. L. (1983) · PubMed · Cited by 118
Schwartsmann, G., Schünemann, H. J., Gorini, C., Filho, A. F. F., Garbino, C., Sabini, G., Musé, I., Leone, L. P. D., & Mans, D. R. A. (2000) · Investigational New Drugs · doi:10.1023/a:1006388031954 · Cited by 111
Howell, A., Mackintosh, J., Jones, M., Redford, J., Wagstaff, J., & Sellwood, R. A. (1988) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(88)90046-6 · Cited by 106
Vogler, W., Winton, E. F., Gordon, D., Raney, M., Go, B., & Meyer, L. (1984) · Blood · doi:10.1182/blood.v63.5.1039.1039 · Cited by 106
High-performance Liquid Chromatographic Analysis of Chemical Stability of 5-aza-2′-Deoxycytidine
Lin, K.-T., Momparlerm, R. L., & Rivard, G. E. (1981) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600701112 · Cited by 102
Bouchard, J., & Momparler, R. L. (1983) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)14371-x · Cited by 102
Synthesis of a 2-deoxy-D-ribofuranosyl-5-azacytosine
Pliml, J., & Šorm, F. (1964) · Collection of Czechoslovak Chemical Communications · doi:10.1135/cccc19642576 · Cited by 101
Phase I and II trials of novel anti-cancer agents: Endpoints, efficacy and existentialism
Eisenhauer, E. A. (1998) · Annals of Oncology · doi:10.1023/a:1008497110734 · Cited by 95
Self-citationTowards a pharmacology of DNA methylation
Szyf, M. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01713-2 · Cited by 93
Willemze, R., Suciu, S., Archimbaud, E., Muus, P., Stryckmans, P. A., Louwagie, E. A., Berneman, Z. N., T'Jean, M., Wijermans, P., Döhner, H., et al. (1997) · PubMed · Cited by 87
Paesmans, M., Sculier, J., Libert, P., Bureau, G., Dabouis, G., Thiriaux, J., Michel, J., Cutsem, O. V., SERGYSELS, R., Mommen, P., et al. (1997) · European Journal of Cancer · doi:10.1016/s0959-8049(97)00325-0 · Cited by 81
Hypomethylation of DNA: An epigenetic mechanism involved in tumor promotion
Counts, J. L., & Goodman, J. I. (1994) · Molecular Carcinogenesis · doi:10.1002/mc.2940110402 · Cited by 79
In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
Momparler, R. L., & Goodman, J. M. (1977) · PubMed · Cited by 74
Graf, W. D., Påhlman, L., Bergström, R., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.345 · Cited by 74
Potential roles of antisense technology in cancer chemotherapy
Crooke, S. T. (2000) · Oncogene · doi:10.1038/sj.onc.1204093 · Cited by 73
Richel, D. J., Colly, L. P., Kluin‐Nelemans, H. C., & Willemze, R. (1991) · British Journal of Cancer · doi:10.1038/bjc.1991.258 · Cited by 70
Momparler, R. L., Bouchard, J., & Samson, J. (1985) · Leukemia Research · doi:10.1016/0145-2126(85)90123-7 · Cited by 67
Lantry, L. E. (1999) · Carcinogenesis · doi:10.1093/carcin/20.2.343 · Cited by 66
5-AZA-2′-deoxycytidine therapy in patients with acute leukemia inhibits DNA methylation
Momparler, R. L., Bouchard, J., Onetto-Pothier, N., & Rivard, G. (1984) · Leukemia Research · doi:10.1016/0145-2126(84)90141-3 · Cited by 61
Schwartsmann, G., Fernandes, M. S., Schaan, M., Moschen, M., Gerhardt, L. M., Leone, L. D., Loitzembauer, B., & Kalakun, L. (1997) · PubMed · Cited by 55
Cell cycle effects and cellular pharmacology of 5-AZA-2?-deoxycytidine
Momparler, R. L., Samson, J., Momparler, L. F., & Rivard, G. (1984) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00269027 · Cited by 51
Carcinogenicity and haemoglobin synthesis induction by cytidine analogues
Carr, B. I., Rahbar, S., Asmeron, Y., Riggs, A. D., & Winberg, C. (1988) · British Journal of Cancer · doi:10.1038/bjc.1988.89 · Cited by 49
Phase II study of 5-azacytidine in solid tumors.
Weiss, A. J., Metter, G. E., Nealon, T. F., et al. (1977) · PubMed · Cited by 49
Beisler, J. A., Abbasi, M. M., Kelley, J. A., & Driscoll, J. S. (1977) · Journal of Medicinal Chemistry · doi:10.1021/jm00216a013 · Cited by 48
Phase I study of 5-azacytidine (NSC-102816) .
Weiss, A. J., Stambaugh, J. E., Mastrangelo, M. J., et al. (1972) · PubMed · Cited by 43
D’Incalci, M., Covey, J. M., Zaharko, D. S., & Kohn, K. W. (1985) · PubMed · Cited by 38
Momparler, R. L., Eliopoulos, N., & Ayoub, J. (2002) · Advances in experimental medicine and biology · doi:10.1007/0-306-46817-4_38 · Cited by 36
A phase I and pharmacokinetic study of dihydro-5-azacytidine (NSC 264880).
Curt, G. A., Kelley, J. A., Fine, R. L., Huguenin, P. N., Roth, J. S., Batist, G., Jenkins, J., & Collins, J. M. (1985) · PubMed · Cited by 33
Clavel, M., Monfardini, S., Fosså, S. D., Smyth, J., Renard, J., & Kaye, S. B. (1992) · Annals of Oncology · doi:10.1093/oxfordjournals.annonc.a058216 · Cited by 28
Covey, J. M., & Zaharko, D. S. (1985) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(85)90207-x · Cited by 27
Roth, B. J., Elson, P. J., Sledge, G. W., Einhorn, L. H., & Trump, D. L. (1993) · Investigational New Drugs · doi:10.1007/bf00874155 · Cited by 24
Phase II trial of 5,6-dihydro-5-azacytidine in pleural malignant mesothelioma
Dhingra, H. M., Murphy, W. K., Winn, R. J., Raber, M. N., & Hong, W. K. (1991) · Investigational New Drugs · doi:10.1007/bf00194548 · Cited by 23
Drug delivery analysis of the Canadian multicenter trial in non-small-cell lung cancer.
Murray, N., Coppin, C., Coldman, A. J., Pater, J. L., & Rapp, E. (1994) · Journal of Clinical Oncology · doi:10.1200/jco.1994.12.11.2333 · Cited by 15
Phase II study of fazarabine in advanced head and neck cancer
Kuebler, J. P., Metch, B., Schuller, D. E., Keppen, M. D., & Hynes, H. E. (1991) · Investigational New Drugs · doi:10.1007/bf00183585 · Cited by 11
Cited by
Das, P. M., & Singal, R. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.151 · Cited by 1,456
DNA methylation and gene silencing in cancer
Baylin, S. B. (2005) · Nature Clinical Practice Oncology · doi:10.1038/ncponc0354 · Cited by 1,154
Thangaraju, M., Cresci, G. A., Liu, K., Ananth, S., Gnanaprakasam, J. P., Browning, D. D., Mellinger, J. D., Smith, S. B., Digby, G. J., Lambert, N. A., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-4466 · Cited by 789
Metabolic reprogramming and epigenetic modifications on the path to cancer
Sun, L., Zhang, H., & Gao, P. (2022) · Protein & Cell · doi:10.1007/s13238-021-00846-7 · Cited by 770
Expression Profiling Reveals Novel Pathways in the Transformation of Melanocytes to Melanomas
Hoek, K., Rimm, D. L., Williams, K. R., Zhao, H., Ariyan, S., Lin, A., Kluger, H. M., Berger, A. J., Cheng, E., Trombetta, E. S., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0731 · Cited by 448
Metadata
- Authors
- Goffin, J., & Eisenhauer, E.
- Venue
- Annals of Oncology
- Publisher
- Elsevier BV
- Published
- 2002-11
- Volume
- 13
- Issue
- 11
- Pages
- 1699-1716
- ISSN
- 0923-7534 (ISSN-L)
- OpenAlex
- W2152757219
- Cited by
- 283
- References
- 112
- FWCI
- 7.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.